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Abstract 25 
Thrombosis is a hallmark of the fatal fungal infection mucormycosis. Yet, the platelet 26 
activation pathway in response to mucormycetes is unknown. In this study we determined 27 
the platelet aggregation potential of Mucor circinelloides (M. circinelloides) NRRL3631, 28 
characterized the signaling pathway facilitating aggregation in response to fungal spores, 29 
and identified the influence of the spore developmental stage upon platelet aggregation 30 
potential. Using impedance and light-transmission aggregometry, we showed that M. 31 
circinelloides induced platelet aggregation in whole blood and in platelet-rich plasma, 32 
respectively. The formation of large spore-platelet aggregates was confirmed by light-sheet 33 
microscopy, which showed spores dispersed throughout the aggregate. Aggregation 34 
potential was dependent on the spore’s developmental stage, with the strongest platelet 35 
aggregation by spores in mid-germination. Inhibitor studies revealed platelet aggregation 36 
was mediated by the low affinity IgG receptor FcγRIIA and integrin αIIbβ3; Src and Syk 37 
tyrosine kinase signaling; and the secondary mediators TxA2 and ADP. Flow cytometry of 38 
antibody stained platelets showed that interaction with spores increased expression of 39 
platelet surface integrin αIIbβ3 and the platelet activation marker CD62P. Together, this is 40 
the first elucidation of the signaling pathways underlying thrombosis formation during a 41 
fungal infection, highlighting targets for therapeutic intervention.  42 
 43 
 44 
 45 
 46 
 47 
 48 
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Introduction 49 
The incidence of invasive fungal infections is on the rise, and this is attributed to the 50 
increasing population of immunosuppressed individuals under the influence of modern 51 
medicine [1-4]. Mucormycosis - a previously uncommon infection - has grown in occurrence 52 
to become the third most common invasive fungal infection after aspergillosis and 53 
candidiasis, respectively [5]. Infection is caused by species of the Mucorales order, with 54 
Rhizopus spp. and Mucor spp. being the most common causative agents [1-4]. Prognosis for 55 
this severe fungal infection is poor, with studies reporting mortality rates in the range of 60-56 
100% [4]. This staggeringly high mortality rate is reflective of the aggressive nature of 57 
infection, and the poor efficacy of antifungal therapeutics currently employed [2, 3]. Risk 58 
factors identified for mucormycosis include uncontrolled diabetes mellitus, diabetes 59 
mellitus with ketoacidosis, organ transplantation and neutropenia [3, 4, 6].  60 
The hallmarks of mucormycosis are considered to be angioinvasion, tissue necrosis and 61 
thrombosis, the latter indicating a potential role of platelets [6]. Platelets have been 62 
identified as major players of the innate immune system with the onset of 63 
thrombocytopenia common during infectious diseases. Infective endocarditis and 64 
septicemia in particular have sparked interest into the interaction between pathogens and 65 
platelets [7-9]. It is unknown if thrombus formation protects from mucormycosis or 66 
exaggerates symptoms by inducing excessive inflammation and tissue necrosis. 67 
The platelet IgG receptor FcγRIIA and integrin αIIbβ3 have been highlighted as crucial to 68 
platelet activation in response to both Gram-negative and Gram-positive bacteria [7-9]. 69 
While the proteins that give rise to bacterial-platelet interaction are strain-specific, platelet 70 
activation is mediated by a common pathway consisting of FcγRIIA, Src and Syk tyrosine 71 
kinase activation, αIIbβ3 engagement and the secondary mediators thromboxane A2 (TxA2) 72 
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and adenosine 5′-diphosphate (ADP) [8, 9]. There is currently little information on the 73 
interaction between platelets and mucormycetes under physiological conditions and the 74 
molecular signaling pathways underlying this interaction. An improved understanding of the 75 
signaling underlying thrombus formation during mucormycosis might offer novel 76 
therapeutic targets to improve current treatment approaches and thus patient outcome. 77 
Hence, we investigated the interaction between the clinical isolate Mucor circinelloides 78 
NRRL3631 and platelets. We show that platelets form aggregates with fungal spores 79 
dependent on the spore developmental stage. Spore aggregation is mediated through the 80 
platelet IgG receptor FcγRIIA, integrin αIIbβ3 and Src and Syk tyrosine kinases, and 81 
secondary mediators TxA2 and ADP. Platelet activation is also associated with increased 82 
expression of platelet surface integrin αIIbβ3 and the platelet activation marker CD62P. 83 
Together, this provides the first elucidation of the signaling pathways underlying thrombosis 84 
formation during mucormycosis highlighting potential strategies to interfere with thrombus 85 
formation. 86 
 87 
Methods 88 
Fungal strains and growth conditions 89 
The Mucor circinelloides strain used was Mucor circinelloides f. sp. lusitanicus strain 90 
NRRL3631, a clinical isolate [10]. The strain was grown on Sabouraud dextrose agar (Merck-91 
Millipore, Billerica, MA, USA) at room temperature for 7 days prior to use.  92 
 93 
Spore preparation for aggregation assays 94 
Spores were collected in phosphate buffered saline (PBS) and centrifuged at 1811 x g for 95 
three min. The spore pellet was washed twice with PBS and then re-suspended in Saboraud 96 
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broth (Sigma-Aldrich, St. Louis, MO, USA). Spores were cultured at 37°C with shaking at 45 97 
rpm, over 0, 3, 6 and 48 hours. Following incubation, spore suspensions were centrifuged at 98 
1811 x g for three min. The spore pellet was washed twice, and re-suspended in PBS at 99 
concentrations to allow for 1:10, 1:20, 1:100 and 1:500 spore:platelet ratios. Spore 100 
suspensions were kept on ice until used for aggregometry.  101 
 102 
Blood preparation 103 
Blood samples were collected from healthy human donors into 4% (w/v) citrate (Sigma-104 
Aldrich, St. Louis, MO, USA). The study design was approved by the University of 105 
Birmingham’s research ethics committee (ERN_11-0175). Blood was centrifuged at 200 x g 106 
for 20 min and platelet-rich plasma (PRP) collected. For light-transmission aggregometry, a 107 
PRP platelet count was taken using Coulter® Z2 Particle Counter in triplicate and averaged. 108 
For multiple-electrode aggregometry, a whole blood platelet count was taken using Sysmex 109 
XN-1000 Hematology Analyzer. 110 
 111 
Platelet aggregometry in PRP 112 
PRP was incubated at 37°C for 1 min and then stirred for 1 min. M. circinelloides NRRL3631 113 
suspension containing appropriate spore numbers for 1:10, 1:20, 1:100 and 1:500 114 
spore:platelet ratios was added to the PRP, and platelet aggregation recorded over 30 min 115 
using light-transmission aggregometer PAP-8E (Bio/Data Corporation, Horsham, PA, USA). 116 
As a positive control, Thrombin Receptor-Activating Peptide (TRAP; Severn Biotech, 117 
Kidderminster, UK) (100 µM) was added to PRP, and as a negative control PBS was added.  118 
 119 
Platelet aggregometry in whole blood 120 
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Whole blood was added to sodium chloride and incubated for 3 min at 37°C. M. 121 
circinelloides NRRL3631 at 3 hours germination, and at a spore concentration allowing for a 122 
spore:platelet ratio of 1:10, was added and platelet aggregation recorded over 30 min using 123 
multiple electrode aggregometer, Multiplate® Analyzer (Roche, Basel, Switzerland) . TRAP 124 
was added to PRP and used as a positive control, and PBS was used as a negative control.  125 
 126 
Cell staining and microscopy 127 
Platelets were stained with CellMask Deep Red Plasma Membrane Stain (1:2000, Thermo 128 
Fisher Scientific, Waltham, MA, USA), and M. circinelloides NRRL3631 spores with 129 
Concanavalin A, Alexa fluor™ 488 conjugate (300 µg ml
-1
, Thermo Fisher Scientific, Waltham, 130 
MA, USA). Formed aggregates were immobilized on poly-L-lysine (Sigma) coated rectangular 131 
coverslips (25x50 mm), fixed using 4% PFA, washed and placed in the imaging chamber filled 132 
with PBS. Orthogonal views of the aggregates were acquired on a Marianas LightSheet 133 
(Intelligent Imaging Innovations, Denver, CO, USA), a dual inverted Selective Plane 134 
Illumination Microscope (diSPIM) which uses two perpendicular 0.8 NA, 40x water 135 
immersion objectives to excite and detect fluorescence in an alternating duty cycle.  136 
Volumes of 200 image planes were captured using both arms sequentially in slice scan mode, 137 
with a step size of 0.5 µm, for both 488 nm and 640 nm excitation wavelengths, on ORCA-138 
Flash4.0 V3 sCMOS cameras (Hamamatsu), driven by SlideBook 6.0 software (Intelligent 139 
Imaging Innovations, Denver, CO, USA). 140 
Image analysis was performed using Fiji software [11], and a maximal intensity projection 141 
was made of a single volume view. For the supplementary movie, the two orthogonal 142 
volumes were registered and deconvolved (joint-deconvolution) using the multiview 143 
Reconstruction plugin [12] and visualized by rotating the 3D volume around the y-axis. 144 
Page 6 of 29
URL: http://mc.manuscriptcentral.com/cpla E-mail: P.Harrison.1@bham.ac.uk
Platelets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 7
 145 
Inhibitor treatments 146 
Inhibition of αIIbβ3 was achieved by pre-incubating platelets with 9 µM eptifibatide 147 
(GlaxoSmithKline, Coventry, UK) for 1 min at room temperature. FcγRIIA was blocked with 148 
10 µM mAbIV.3 (hybridoma from American Tissue Culture Corporation (Manassas, Virginia), 149 
Src and Syk tyrosine kinases with 4 µM dasatinib (D-3307, LC Laboratories, Woburn, MA, 150 
USA) and 10 µM PRT-060318 (AdipoGen Life Sciences, Liestal, Switzerland) respectively, and 151 
secondary mediators TxA2 and ADP with 30 µM Indomethacin (I7378, Sigma-Aldrich, St. 152 
Louis, MO, USA) and 2 U Apryase (A6535, Sigma-Aldrich, St. Louis, MO, USA) respectively. 153 
Platelet aggregation was assess d by light-transmission in a PAP-8E aggregometer over 30 154 
min.  155 
 156 
Platelet receptor labeling 157 
Conjugated anti-human CD32 (#60012; mouse; StemCell Technologies, Vancouver, Canada) 158 
and anti-mouse 2° Alexa Fluor® 488 conjugate (A10680; goat; Invitrogen, Carlsbad, CA, USA) 159 
was used to label FcγRIIA. Anti-Human CD41a-APC (BD559777; mouse; BD Biosciences, San 160 
Jose, CA, USA) was used to label αIIbβ3. CD62P-FITC (BC A07790; mouse; Beckman Coulter, 161 
Brea, CA, USA) was used to label CD62P. Platelet aggregation was assessed by light-162 
transmission in a PAP-8E aggregometer over 30 min. Receptor antibody labels were added 163 
to samples for 30 min prior to flow cytometry assays. Flow cytometry analysis was 164 
conducted using BD Accuri™ C6 Plus (BD Biosciences, Oxford, UK). Samples were run for 165 
10000 events, and cell count vs fluorescence recorded. 166 
 167 
Statistical analysis 168 
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Statistical analysis was conducted using GraphPad Prism 6.0. Data is presented as mean ± 169 
SEM, unless stated otherwise. Data was analysed using the one-way analysis of variance 170 
(ANOVA) with post hoc Dunnett’s multiple comparison test, Mann-Whitney U-test or 171 
Kruskal-Wallis test with post hoc Dunn’s multiple comparison test, as indicated in the figure 172 
legends.  P<0.05 was deemed to be statistically significant. Technical repeats were 173 
conducted at n=3, and biological repeats at n=5 unless otherwise stated. 174 
 175 
Results 176 
Mucor circinelloides NRRL3631 induces platelet aggregation in whole human blood and 177 
PRP 178 
Thrombus formation during mucormycosis might be induced by fungal invasion of blood 179 
vessels, and thus formation of a platelet-reactive surface, or direct interaction between 180 
platelets and the fungus. Therefore, we investigated the potential of the clinical isolate 181 
Mucor circinelloides NRRL3631 to induce platelet aggregation qualitatively and 182 
quantitatively.  183 
Initially, we visualized spore-platelet interaction by dual inverted Selective Plane 184 
Illumination fluorescence microscopy (diSPIM), which gives isotropic resolution in 3 185 
dimensions. M. circinelloides spores were stained with Concanavalin A, Alexa Fluor™ 488 186 
conjugate and platelets in plasma-rich platelets (PRP) with CellMask Deep Red Plasma 187 
Membrane Stain. M. circinelloides spores were incubated in PRP at a 1:10 spore:platelet 188 
ratio under stirring conditions in the PAP-8E aggregometer and formed aggregates were 189 
fixed onto glass coverslips. Fluorescence microscopy revealed M. circinelloides NRRL3631 190 
spores to be contained within large platelet aggregates with individual spores being 191 
surrounded by platelets (Figure 1Ai & ii and Supplementary Movie 1).   192 
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We then quantified this interaction by light transmission aggregometry. Experiments were 193 
performed in PRP using 1:10, 1:20, 1:100 and 1:500 spore:platelet ratios. The agonist 194 
thrombin-related-activating peptide (TRAP) induced maximal platelet aggregation (91.8 ± 195 
2.0%). M. circinelloides NRRL3631 induced platelet aggregation in a concentration-196 
dependent manner, with significant platelet aggregation occurring at 1:10 and 1:20 197 
spore:platelet ratios (1:10: 56.0 ±12.3% and 1:20: 52.8% ±14.6% platelet aggregation; 198 
P<0.01) (Figure 1B).  199 
To examine the physiological relevance of platelet aggregation in response to 200 
mucormycetes, we determined the platelet aggregation potential of M. circinelloides 201 
NRRL3631 in whole blood using impedance aggregometry. M. circinelloides NRRL3631 was 202 
added to whole blood at a spore:platelet ratio of 1:10, and platelet aggregation assessed. M. 203 
circinelloides NRRL3631 induced significant platelet aggregation (180 ± 16U; P<0.05) in 204 
comparison to PBS (81 ± 16U) (Figure 1C).  205 
In summary, these data show that platelets interact with mucormycete spores to form large 206 
platelet-spore aggregates. This indicates that thrombus formation during mucormycosis can 207 
be mediated by a direct platelet response to fungal spores.  208 
 209 
Platelet aggregation in response to Mucor circinelloides NRRL3631 is supported by the 210 
FcγRIIA receptor and integrin αIIbβ3 211 
Having shown that platelets form aggregates with mucormycete spores, we next wanted to 212 
identify the receptor(s) and downstream signaling components mediating this interaction. 213 
Aggregation studies with washed platelets did not induce aggregation suggesting the 214 
requirement of a serum factor. Therefore, this study performed aggregations in PRP with 215 
the focus to elucidate the receptors and downstream signaling mediators. The platelet low 216 
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affinity immune receptor, FcγRIIA has been identified as a key receptor in platelet activation 217 
in response to bacterial pathogen through the result of antibody-pathogen interaction [8, 9, 218 
13, 14]. We hypothesized that FcγRIIA plays a key role in the induction of platelet 219 
aggregation by M. circinelloides NRRL3631 in view of the dependency on plasma. In addition, 220 
platelet integrin αIIbβ3, the most abundant platelet surface glycoprotein, has been shown 221 
to be essential for platelet activation by bacteria [13-16]. To investigate whether platelet 222 
aggregation in response to M. circinelloides NRRL3631 is supported by FcγRIIA and αIIbβ3 223 
engagement, platelets were treated with the FcγRIIA blocking mAb IV.3 or αIIbβ3 inhibitor 224 
eptifibatide, prior to M. circinelloides NRRL3631 exposure. Blocking FcγRIIA significantly 225 
decreased platelet aggregation in response to M. circinelloides NRRL3631 (1:10 (-)mAb IV.3: 226 
48.8 ± 9.58%; (+) mAb IV.3: 12.8 ± 10.57%; P<0.05) (Figure 2A). Platelet aggregation was 227 
abrogated by eptifibatide (1:10 (-)eptifibatide: 58.0 ± 7.46%; (+)eptifibatide: 0.60 ± 0.25%; 228 
P<0.01) and (Figure 2B).   229 
Upon platelet activation, expression of surface αIIbβ3 is upregulated, further supporting 230 
platelet-platelet interaction and therefore aggregation [7, 13, 15], including during bacterial 231 
infection [8, 9]. Platelet surface integrin αIIbβ3 expression levels are enhanced as a result of 232 
platelet activation by means of α-granule release [17]. We thus investigated the expression 233 
patterns of FcγRIIA and αIIbβ3 by flow cytometry after antibody labeling. Platelet expression 234 
levels of FcγRIIA were not altered in response to M. circinelloides NRRL3631 spores under 235 
aggregating conditions (Figure 2C). In contrast, surface αIIbβ3 levels were increased in 236 
response to M. circinelloides NRRL3631 spores under the same conditions (Figure 2D). 237 
Thus, this shows that platelets respond to fungal spores through interaction with the IgG 238 
receptor FcγRIIA and integrin αIIbβ3. Subsequently, αIIbβ3 surface levels are upregulated to 239 
further support platelet aggregation.  240 
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 241 
Mucor circinelloides NRRL3631 activates Src and Syk signaling cascades and induces 242 
platelet activation supported by secondary mediators TxA2 and ADP. 243 
The two identified interaction platelet receptors FcγRIIA and αIIbβ3 both activate 244 
downstream Src and Syk tyrosine kinases [16]. To test if the interaction of M. circinelloides 245 
NRRL3631 with platelets also results in the activation of Src and Syk, platelets were treated 246 
with Src inhibitor Dasatinib, and Syk inhibitor PRT-060318 prior to M. circinelloides 247 
NRRL3631 exposure. Dasatinib and PRT-060318 inhibited platelet aggregation in response to 248 
M. circinelloides NRRL3631 (Figure 3A).  249 
The platelet α-granules activation marker CD62P (P-selectin) is expressed on the platelet 250 
surface upon platelet activation [18]. Platelets were antibody-labeled for P-selectin, and 251 
expression levels measured pre- and postexposure to M. circinelloides NRRL3631 spores 252 
using flow cytometry. P-selectin expression levels were markedly increased following 253 
exposure to M. circinelloides spores indicating that platelets are activated by M. 254 
circinelloides NRRL3631 under aggregating conditions (Figure 3Bi). Under non-aggregating 255 
conditions by means of eptifibatide platelet pre-treatment, P-selectin expression was 256 
negligible, suggesting that αIIbβ3 activation is crucial to platelet activation by 257 
M. circinelloides NRRL3631 interaction (3Bii).  258 
Whilst platelet aggregation in response to the agonist TRAP occurs rapidly within minutes, 259 
platelet aggregation in response to spores is characterised by a lag-phase (Figure 3C). This 260 
long incubation time needed to detect spore-induced platelet aggregation suggests that 261 
secondary mediators might be required for the platelet response. The secondary mediators, 262 
thromboxane A2 (TxA2) and adenosine 5′-diphosphate (ADP), are released upon platelet 263 
activation and act to support clot consolidation [19, 20]. Platelets were treated with TxA2 264 
Page 11 of 29
URL: http://mc.manuscriptcentral.com/cpla E-mail: P.Harrison.1@bham.ac.uk
Platelets
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review Only
 12
inhibitor, indomethacin, and ADP inhibitor, apyrase, prior to M. circinelloides NRRL3631 265 
spore exposure. TxA2 and ADP inhibition independently (e.g. at 1:10 spore:platelet ratio: 266 
70.0 ± 6.0%; (+)indomethacin: 24.3 ± 6.8%; (+)apyrase: 37.3 ± 12.2%) and in combination 267 
(e.g. at 1:10 spore: platelet ratio (+)indomethacin(+)apyrase: 18.3 ± 6.1%) reduced M. 268 
circinelloides NRRL3631-induced platelet aggregation (Figure 3D).  269 
In summary, these data demonstrate that spore interaction with platelet receptors activates 270 
downstream Src and Syk tyrosine kinases leading to platelet activation including the release 271 
of α-granules shown by increased surface expression of the activation marker P-selectin and 272 
by increased expression of integrin αIIbβ3. Activation is supported by secondary mediators 273 
TxA2 and ADP.  274 
 275 
Mucor circinelloides NRRL3631 spore developmental stage impacts on platelet 276 
aggregation  277 
Mucormycete spores undergo both metabolic and structural changes during development 278 
from spore to hyphae [21]. The host encounters these different developmental stages 279 
during infection, thus requiring a dynamic response. We hypothesized that the 280 
developmental stage of the M. circinelloides NRRL3631 spore would influence its platelet 281 
aggregation potential.  282 
We first identified stages of germination at which a significant increase in spore size occurs. 283 
Resting spores at the start of germination, displayed a surface area of 19.8 ± 3.0 µm
2
 (Figure 284 
4A). Spores significantly increased in size at 3 hours germination (34.1 ± 6.8µm
2
; P<0.05), 285 
and furthermore at 6 hours germination (49.9 ± 15.4 µm
2
; P<0.05). Hyphae formation was 286 
observed on spores at 48 hours germination (hyphae formation efficiency: 27.5 ± 8.5%) 287 
(Figure 4B).  288 
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We investigated M. circinelloides NRRL3631 spores at 0, 3 and 6 hours germination, and 289 
hyphae at 48 hours germination in PRP, and showed that the developmental stage of M. 290 
circinelloides NRRL3631 influences its platelet aggregation potential (Figure 4C).   291 
At the beginning of germination, M. circinelloides NRRL3631 induced significant platelet 292 
aggregation (1:10: 15.6 ± 10.2%; P<0.05), however to a lesser degree than spores at 3 hours 293 
germination (1:10: 56.0 ±12.3%; P<0.01). As M. circinelloides NRRL3631 spore development 294 
progressed beyond 3 hours germination, platelet aggregation potential declined (6 hours 295 
germination; 1:10: 32.6 ± 14.3%). Moreover, M. circinelloides NRRL3631 spores exhibiting 296 
hyphae formation at 48 hours germination induced negligible platelet aggregation (1:10: 297 
2.80 ± 1.11%). 298 
Together, this shows that the platelet response to M. circinelloides varies with the spore 299 
developmental stage, indicating a dynamic interaction pattern that needs to be considered 300 
for mucormycosis treatment approaches.  301 
 302 
Discussion 303 
Clinical management of mucormycosis remains a challenge whilst the disease incidence is 304 
on the rise. Many of our antifungal agents are ineffective against mucormycetes and 305 
associated with toxic side effects. The gold standard therapy still is surgical debridement 306 
often leading to long-term disability. Together, this results in extremely high mortality in 307 
patients with mucormycosis and highlights the need for more effective therapeutic 308 
strategies.  309 
Thrombosis is a hallmark of mucormycosis. It is currently not clear if thrombus formation is 310 
beneficial for the patient by containing the fungus or detrimental due to reduced oxygen 311 
supply and subsequent tissue necrosis. Ability to manipulate the platelet – spore interaction, 312 
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either by enhancing or inhibiting, might be a promising medical approach to improve 313 
patient outcome.  314 
To identify potential targets for medical intervention, we here elucidated components of 315 
the signaling pathway underlying platelet – spore interaction.  Our data demonstrate that 316 
platelets form aggregates surrounding mucormycete spores, the infectious agent of 317 
mucormycosis. This aggregation is dose-dependent. Platelet activation by spores is 318 
mediated through the platelet receptors FcγRIIA and αIIbβ3 and, the Syk/Src signaling 319 
cascade to induces α-granules release. This activation is supported by the secondary 320 
mediators TxA2 and ADP. The dose-dependent nature of platelet aggregation (Figure 1B) 321 
mimics the all-or-nothing response previously described for E. coli and Gram-positive 322 
bacteria [8, 9] suggesting a positive feedback mechanism supporting platelet aggregation. 323 
Inhibitor studies suggest that FcγRIIA is an essential receptor for platelet activation in 324 
response to fungal spores (Figure 2A).  As no aggregation was observed in washed platelets, 325 
this suggests that one or more plasma factor(s) mediate this interaction. The current 326 
literature suggests these are IgG, by forming an immune complex with spores, to interact 327 
with FcγRIIA and fibrinogen as a bridging molecule to interact with αIIbβ3 [9]. Whilst we 328 
currently do not know the fungal cell wall components interacting with platelets and 329 
whether this interaction is direct or indirect, binding of fibrinogen has been reported to 330 
Candida albicans cell wall [22]. Due to the constant exposure of humans to these 331 
environmentally ubiquitous fungal spores, it is also highly likely that humans have 332 
circulating antibodies to support the platelet-spore interaction. Research on bacterial 333 
interaction with platelets has shown that several platelet receptors are required for efficient 334 
platelet activation [8, 9, 23-25]. Similarly, platelet activation after spore encounter also 335 
requires integrin αIIbβ3 (Figure 2B) and secondary mediators TxA2 and ADP supporting the 336 
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notion of positive feedback mechanisms reinforcing initial FcγRIIA activation. Inside-out 337 
signaling has previously been reported for αIIbβ3 to induce secondary platelet-platelet 338 
aggregation after initial activation in response to a stimulus through FcγRIIA [8, 26, 27]. Thus 339 
both receptors might have dual functionality in initiating as well as amplifying thrombus 340 
formation. Together, these signaling events correspond to those reported previously for a 341 
range of bacterial interaction with platelets [8, 9] and thus indicate that the platelet 342 
response to infectious particles is conserved.  343 
The conserved nature of the platelet activation pathway in response to pathogens might be 344 
indicative of a protective innate immune function performed by platelets. Attachment of 345 
platelets to fungal hyphae has shown to result in hyphal damage and reduced viability [6, 346 
28]. Yet, a potential detrimental outcome due to excessive platelet aggregation causing 347 
tissue necrosis, similar to exaggerated inflammatory responses needs to be considered. The 348 
release of immune-stimulatory effectors such as pro-inflammatory and pro-necrotic factor 349 
TNF-α and phagocyte chemoattractant TGF-β in α-granules [29] would support this idea. In 350 
the context of mucormycosis, thrombocytopenia has been suggested as factor for severe 351 
disease and poor patient outcome [30, 31] suggesting that thrombus formation contributes 352 
to disease pathology.  353 
During filamentous fungal infections, platelets encounter a range of morphological 354 
structures. Whilst initial infection often occurs through inhalation of spores, the propagules 355 
then undergo a developmental program of metabolic and physiological changes to form 356 
invasive hyphae. During this germination process, water uptake causes the spore to ‘swell’ 357 
and undergo a change in both size and structural composition. As mucormycete spores 358 
germinate, there is a depletion of melanin from the outer surface exposing a glucan-rich 359 
outer wall [32]. In the latter stages of germination hyphae are formed, the outer wall of 360 
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which is chitosan-rich and formed by the germinating spore’s inner wall [32]. During the 361 
preliminary stages of M. circinelloides NRRL3631 germination we saw a stark increase in 362 
platelet aggregation potential, reaching a peak at 3 hours germination, where spores are 363 
between resting and maximal swelling stage. Surprisingly, platelet aggregation potential of 364 
M. circinelloides NRRL3631 declined towards the latter stages of germination as spores 365 
reach their maximal swelling stage, and M. circinelloides hyphal structures appeared to 366 
induce negligible platelet aggregation altogether. Two plausible explanations for the change 367 
in mucormycete spore platelet aggregation potential during germination are: (I) 368 
compositional changes of the germinating mucormycete spore, and (II) the secretion of 369 
platelet inhibitory fungal secretory factors. The secretion of platelet inhibitory fungal 370 
secretory factor has been shown in Candida albicans [33]. C. albicans activates platelets but 371 
inhibits aggregation to fibrinogen, in part via the fungal secretory factor gliotoxin [33].  372 
In summary, this is the first analysis of the signaling underlying platelet aggregation in 373 
response to fungi and thus providing a better understanding of this interaction. The 374 
interaction with fungi is dependent on the developmental stage of the fungus, which might 375 
lead to different outcomes of this interaction that can be beneficial as well as detrimental to 376 
the host. This needs to be carefully considered for the clinical management of patients. 377 
During mucormycosis, platelets have the potential to inhibit the germination process of 378 
mucormycetes [6]. We identify several receptors and the downstream signaling 379 
components that could be targeted with already available medical interventions as 380 
preventative measures inhibiting disease onset (i.e. spore germination) or by targeting 381 
thrombus formation to improve current disease outcome.  382 
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Figure Legends 503 
Figure 1 Mucor circinelloides NRRL3631 induces platelet aggregation in whole blood and 504 
PRP. (A) M. circinelloides NRRL3631 spores (green) interact with human platelets (magenta) 505 
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to form large complex structures. We imaged a total of 17 aggregates and show here images 506 
for two of those. These images show (i) an optical section through a platelet and spore 507 
aggregate and (ii) the maximal intensity projection of the (single view diSPIM) 3D volume of 508 
the spore-induced platelet aggregate. Images are representative of 17 aggregates from two 509 
independent experiments. Complexes were visualized by dual inverted Selective Plane 510 
Illumination Microscopy (diSPIM) using 40x objectives and analysed on Image J (FIJI); scale 511 
bar: 10µm. (B) Platelet aggregation in response to TRAP, PBS and M. circinelloides NRRL3631 512 
over increasing spore:platelet ratios was measured in PRP using light-transmission 513 
aggregometry over 30 min. Significant platelet aggregation was induced by M. circinelloides 514 
NRRL3631 at a 1:10 and 1:20 spore:platelet ratio. Notably M. circinelloides NRRL3631 515 
induced platelet aggregation in a concentration-dependent manner. Data shown are 516 
mean±SEM of five independent experimental repeats; **P<0.01, Mann-Whitney U test. (C) 517 
Platelet aggregation in response to TRAP, PBS and Mucor circinelloides NRRL3631 spores 518 
was measured in whole blood using multiple-electrode aggregometry over 30 min. M. 519 
circinelloides NRRL3631 spores induced significant platelet aggregation in whole blood. Data 520 
shown are mean±SEM of five independent experimental repeats; *P<0.05, Mann-Whitney U 521 
test. 522 
 523 
Figure 2 Platelet aggregation in response to Mucor circinelloides NRRL3631 is supported 524 
by the FcγRIIA receptor and integrin αIIbβ3 (A) Mucor circinelloides NRRL3631 is recognized 525 
by the FcγRIIA receptor. Platelet aggregation in response to M. circinelloides NRRL3631 in 526 
the presence and absence of FcγRIIA blocking mAB IV.3 was measured in PRP using light-527 
transmission aggregometry over 30 min. mAb IV.3 significantly inhibited platelet 528 
aggregation in response to M. circinelloides NRRL3631. Data shown are mean ±SEM of five 529 
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independent experimental repeats; **P<0.01, Mann-Whitney U test. (B) Platelet 530 
aggregation in response to Mucor circinelloides NRRL3631 is supported by the αIIbβ3 531 
integrin. Platelet aggregation in response to M. circinelloides NRRL3631 spores in the 532 
presence and absence of αIIbβ3 inhibitor, eptifibatide, was measured in PRP using light-533 
transmission aggregometry over 30 min. Eptifibatide significantly inhibited platelet 534 
aggregation in response to M. circinelloides NRRL3631. Data shown are mean ±SEM of five 535 
independent experimental repeats;  *P<0.05, **P<0.01, Mann-Whitney U test. (C) Mucor 536 
circinelloides NRRL3631-platelet interaction does not affect FcγRIIA platelet surface 537 
expression but does (D) increase αIIbβ3 platelet surface expression. Platelets were labelled 538 
for FcγRIIA, using conjugated anti-human CD32 + anti-mouse 2° Alexa 488, and αIIbβ3, using 539 
APC-Mouse Anti-Human CD41a.  Platelet surface expression of FcγRIIA and αIIbβ3 were 540 
read using flow cytometry.  541 
 542 
Figure 3 Mucor circinelloides NRRL3631 activates Src and Syk signaling cascades and 543 
induces platelet activation supported by secondary mediators TxA2 and ADP (A) Mucor 544 
circinelloides NRRL3631 activates the Src and Syk signaling cascades. Platelet aggregation in 545 
response to M. circinelloides NRRL3631 in the presence and absence of Src receptor 546 
inhibitor, dasatinib (4 µM), and Syk inhibitor, PRT-060318 (10 µM), was measured in PRP 547 
using light-transmission aggregometry over 30 min. Dasatinib significantly inhibited platelet 548 
aggregation in response to M. circinelloides NRRL3631. PRT-060318 also significantly 549 
inhibited platelet aggregation in response to M. circinelloides NRRL3631. Data shown are 550 
mean ±SEM of five independent experimental repeats; **P<0.01, Mann-Whitney U test. (B) 551 
M. circinelloides NRRL3631 activates platelets under (i) aggregating conditions but not 552 
under (ii) non-aggregating conditions. Platelet aggregation in response to M. circinelloides 553 
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NRRL3631 in the presence and absence of αIIbβ3  inhibitor, eptifibatide, and was measured 554 
in PRP using light-transmission aggregometry over 30 min. Platelets were labelled for CD62P 555 
activation marker using CD62P-FITC and surface expression read using flow cytometry. (i) 556 
Under aggregating conditions CD62P expression is enhanced following M. circinelloides 557 
NRRL3631 exposure. (ii) Under non-aggregating conditions, change in CD62P expression is 558 
undetectable following M. circinelloides NRRL3631 exposure. (C) Example aggregation 559 
traces showing fast initiation of platelet aggregation in response to the agonist TRAP and a 560 
lag phase before induction of platelet activation in response to fungal spores. (D) Secondary 561 
mediators TxA2 and ADP play a role in M. circinelloides NRRL3631-induced platelet 562 
aggregation. Platelet aggregation in response to M. circinelloides NRRL3631 in the presence 563 
and absence of TxA2 inhibitor, indomethacin (30 µM), and ADP inhibitor, apyrase (2 U), was 564 
measured in PRP using light-transmission aggregometry over 30 min. Indomethacin 565 
significantly inhibited platelet aggregation in response to M. circinelloides NRRL3631, and 566 
apyrase markedly reduced platelet aggregation in response to M. circinelloides NRRL3631. 567 
Combined indomethacin and apyrase treatment significantly further reduced platelet 568 
aggregation in response to M. circinelloides NRRL3631.  Data shown are mean±SEM of three 569 
independent experimental repeats; *P<0.05, **P<0.01, One-way ANOVA with post hoc 570 
Dunnett’s multiple comparison test.  571 
 572 
Figure 4 Mucor circinelloides NRRL3631 spore developmental stage impacts on platelet 573 
aggregation (A) Mucor circinelloides spore development. M. circinelloides NRRL3631 spore 574 
swelling was investigated over 0, 3 and 6 hours. Spores were visualized by DIC light 575 
microscopy at 60x magnification; scale bar: 5µm. 100 spores from each time point were 576 
analysed on ImageJ: a length and width measurement (in µm) was taken from each spore 577 
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and the spore area calculated ((length/2)*(width/2)*π)). M. circinelloides NRRL3631 spores 578 
exhibited significant increase in size from 0 to 3 hours germination, and from 3 to 6 hours 579 
germination. Data shown are pooled data points with mean±SD of three independent 580 
experimental repeats, each analysing the surface area of 100 spores per incubation period; 581 
*** P<0.001, one-way ANOVA with post hoc Dunnett’s multiple comparison test. (B) M. 582 
circinelloides hyphae formation efficiency. M. circinelloides NRRL3631 hyphae formation 583 
was studied at 48 hours germination. Spores were visualized by DIC light microscopy at 60x 584 
magnification; scale bar: 10µm. 100 spores at 48 hours germination were analysed on 585 
ImageJ to determine the percentage of hyphae per 100 spores. Data shown are mean±SEM 586 
from three independent experimental repeats; scale bar: 10µm. (C) Platelet aggregation 587 
potential is dependent on the developmental stage of Mucor circinelloides NRRL3631. 588 
Platelet aggregation in response to M. circinelloides NRRL3631 spores over progressive 589 
developmental stages, was measured in PRP using light-transmission aggregometry over 30 590 
min. M. circinelloides NRRL3631 spores at time zero germination induced significant platelet 591 
aggregation at a 1:10 spore:platelet ratio. M. circinelloides NRRL3631 spores at 3 hours 592 
germination induced significant platelet aggregation at a 1:10 and 1:20 spore:platelet ratio 593 
(data from Figure 2B). M. circinelloides NRRL3631 spores at 6 hours induced aggregation to 594 
a lesser degree than those at 3 hours germination, and spores at 48 hours germination 595 
induced negligible platelet aggregation. Data shown are mean±SEM of five independent 596 
experimental repeats; *P<0.05, **P<0.01, Kruskal-Wallis test. 597 
 598 
Supplementary Movie 1 Platelet spore aggregate. 3D visualization of the platelet spore 599 
aggregate shown in Figure 1 Aii.  600 
 601 
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